Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer research, Paclitaxel, Metastasis, Medicine, Triple-negative breast cancer, and PLK1.
Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
EZH2-Mediated Inactivation of IFN-γ-JAK-STAT1 Signaling Is an Effective Therapeutic Target in MYC-Driven Prostate Cancer
PDK1 Signaling Toward PLK1–MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy